Stock Price
162.28
Daily Change
1.60 1.00%
Monthly
-2.03%
Yearly
7.99%
Q2 Forecast
172.58

IQVIA Holdings reported $8.34B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Accenture USD 20.96B 1.06B Dec/2025
Agilent USD 2.23B 113M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Cardinal Health USD 43.31B 3.05B Dec/2025
Celltrion KRW 4.01T 343.96B Sep/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cigna USD 56.34B 111M Dec/2025
Cognizant Technology Solutions USD 3.66B 226M Dec/2025
Computer Programs Systems USD 57.96M 4.21M Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
CVS Health USD 88.69B 4B Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.34B 62M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Elevance Health USD 45.31B 4.27B Mar/2026
Humana USD 16.35B 166M Dec/2025
IBM USD 40.1B 1.44B Mar/2026
Illumina USD 1.59B 377M Dec/2025
Infosys INR 499.34B 35.36B Dec/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Laboratory Of America USD 2.82B 194.3M Dec/2025
Malin Corporation EUR 1000K 500K Dec/2024
McKesson USD 68.13B 100M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
Publicis EUR 23.89B 3.02B Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Revvity USD 1.33B 108.5M Dec/2025
Sartorius EUR 2.11B 145.8M Mar/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
UnitedHealth USD 114.9B 629M Dec/2025
Veeva Systems USD 1.64B 692.18M Dec/2025
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 1.24B 11.8M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025